Phase 1 Study to Determine Safety, Blood PK and Lung Penetration

NCT01034774 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: ACHN-490 Injection
DRUG: Placebo (normal saline)

Sponsor

Achaogen, Inc.